Potentially ‘life changing’ arthritis drug listed on PBS Tofacitinib will be listed despite lingering concerns related to an increased risk of blood clots and potentially death when taken in high doses.
Australia has a new action plan for arthritis Experts believe the common condition could be better treated and prevented.
Safety concerns over popular arthritis drug The TGA issued an alert after a study found high doses of tofacitinib could lead to increased risk of blood clots in the lungs and potentially death.
Important psoriatic arthritis drug listed on the PBS Ixekizumab is available for patients with the life-long condition, which causes joints to become stiff, painful and often swollen.
Drug for ‘hidden’ arthritis to be subsidised from December Australians with severe inflammatory spinal arthritis will be able to access a vital drug for less than $40 – instead of $1300 – when it is listed on the Pharmaceutical Benefits Scheme from 1 December.
New drugs listed on the PBS for rheumatoid arthritis, cystic fibrosis and ADHD Vital drugs for rheumatoid arthritis, cystic fibrosis and attention deficit hyperactivity disorder will now be more accessible for patients.